Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-24 @ 7:06 PM
NCT ID:
NCT00196157
Eligibility Criteria:
Inclusion Criteria:
* age between 18 and 80 years
* symptomatic persistent (\> 7 days lasting) atrial fibrillation
* at least one unsuccessful cardioversion or atrial fibrillation relapse in the first 3 months after cardioversion despite antiarrhythmic drug therapy
* oral anticoagulation (\> 4 weeks prior to ablation)
Exclusion Criteria:
* moderate to severe valvular heart disease
* congenital heart disease
* LV-EF \< 35%
* reversible cause for atrial fibrillation (e.g., hyperthyreosis)
* prior left atrial ablation or Maze operation
* left atrial thrombus
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00196157
Study Brief:
Protocol Section:
NCT00196157